Thursday, February 4, 2016 5:02:00 AM PDT | VentureDeal
Oro Valley, Arizona -- Diagnostics technology company BioDirection has raised $4 million in new venture investment.
BioDirection is developing a diagnostic product to test for traumatic brain injury. The company says that "concussions represent more than 85% of total brain injuries worldwide." Provident Healthcare Capital and other undisclosed investors made the investment. BioDirection said it would use the funding for the final stages of development and beginning commercialization of its point of care diagnosis system for concussions and other traumatic brain injuries.
Email Page | Print Page
Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?
Start your Free 14 Day Trial now – no obligation or credit card required.
